259 related articles for article (PubMed ID: 37858186)
1. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
2. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy.
Zhang L; Song A; Yang QC; Li SJ; Wang S; Wan SC; Sun J; Kwok RTK; Lam JWY; Deng H; Tang BZ; Sun ZJ
Nat Commun; 2023 Sep; 14(1):5355. PubMed ID: 37660063
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis/pyroptosis dual-inductive combinational anti-cancer therapy achieved by transferrin decorated nanoMOF.
Xu R; Yang J; Qian Y; Deng H; Wang Z; Ma S; Wei Y; Yang N; Shen Q
Nanoscale Horiz; 2021 Apr; 6(4):348-356. PubMed ID: 33687417
[TBL] [Abstract][Full Text] [Related]
4. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis.
Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q
ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091
[TBL] [Abstract][Full Text] [Related]
5. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy.
Yang J; Ma S; Xu R; Wei Y; Zhang J; Zuo T; Wang Z; Deng H; Yang N; Shen Q
J Control Release; 2021 Jun; 334():21-33. PubMed ID: 33872626
[TBL] [Abstract][Full Text] [Related]
6. Hydrazide/Metal/Indocyanine Green Coordinated Nanoplatform for Potentiating Reciprocal Ferroptosis and Immunity against Melanoma.
Hou G; Qian J; Wang Y; Xu W; Guo M; Li Z; Wang J; Suo A
ACS Appl Mater Interfaces; 2023 Aug; 15(31):37143-37156. PubMed ID: 37498789
[TBL] [Abstract][Full Text] [Related]
7. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ.
Cai J; Yi M; Tan Y; Li X; Li G; Zeng Z; Xiong W; Xiang B
J Exp Clin Cancer Res; 2021 Jun; 40(1):190. PubMed ID: 34108030
[TBL] [Abstract][Full Text] [Related]
8. Disruption of dual homeostasis by a metal-organic framework nanoreactor for ferroptosis-based immunotherapy of tumor.
Zhang K; Ma Z; Li S; Wu Y; Zhang J; Zhang W; Zhao Y; Han H
Biomaterials; 2022 May; 284():121502. PubMed ID: 35390708
[TBL] [Abstract][Full Text] [Related]
9. Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy.
Wang X; Luo J; Wang J; Cao J; Hong Y; Wen Q; Zeng Y; Shi Z; Ma G; Zhang T; Huang P
ACS Appl Mater Interfaces; 2023 Feb; 15(5):6442-6455. PubMed ID: 36700645
[TBL] [Abstract][Full Text] [Related]
10. Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy.
Li J; Zhou Y; Liu J; Yang X; Zhang K; Lei L; Hu H; Zhang H; Ouyang L; Gao H
J Control Release; 2022 Dec; 352():313-327. PubMed ID: 36272661
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy.
Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W
Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.
Guo W; Wu Z; Chen J; Guo S; You W; Wang S; Ma J; Wang H; Wang X; Wang H; Ma J; Yang Y; Tian Y; Shi Q; Gao T; Yi X; Li C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738798
[TBL] [Abstract][Full Text] [Related]
13. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy.
Deng W; Shang H; Tong Y; Liu X; Huang Q; He Y; Wu J; Ba X; Chen Z; Chen Y; Tang K
J Nanobiotechnology; 2024 Mar; 22(1):97. PubMed ID: 38454419
[TBL] [Abstract][Full Text] [Related]
14. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
15. Boosting cancer immunotherapy by biomineralized nanovaccine with ferroptosis-inducing and photothermal properties.
Ma S; Liang X; Yang N; Yang J; Zhang J; Pan X; Wei Y; Liu Z; Shen Q
Biomater Sci; 2023 Jan; 11(2):518-532. PubMed ID: 36468623
[TBL] [Abstract][Full Text] [Related]
16. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.
Liu Z; Kang R; Yang N; Pan X; Yang J; Yu H; Deng W; Jia Z; Zhang J; Shen Q
J Colloid Interface Sci; 2024 Mar; 658():100-113. PubMed ID: 38100967
[TBL] [Abstract][Full Text] [Related]
18. Anti-PD-L1 DNAzyme Loaded Photothermal Mn
Liu P; Shi X; Peng Y; Hu J; Ding J; Zhou W
Adv Healthc Mater; 2022 Apr; 11(8):e2102315. PubMed ID: 34841741
[TBL] [Abstract][Full Text] [Related]
19. A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells.
Zhou S; Shang Q; Ji J; Luan Y
ACS Appl Mater Interfaces; 2021 Oct; 13(40):47407-47417. PubMed ID: 34597015
[TBL] [Abstract][Full Text] [Related]
20. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.
Zhou B; Zhang JY; Liu XS; Chen HZ; Ai YL; Cheng K; Sun RY; Zhou D; Han J; Wu Q
Cell Res; 2018 Dec; 28(12):1171-1185. PubMed ID: 30287942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
